These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1690476)

  • 1. Clinical studies on the effectiveness of prazosin HCl (Minipress tablets) in the treatment of dysuria accompanying benign prostatic hyperplasia.
    Aoki H; Ohninata M; Tsuzuki T; Ohhori M; Shiraiwa Y; Yamaguchi O; Kobayashi M; Yokota T; Numazato S; Sakuma S
    Urol Int; 1990; 45 Suppl 1():18-25. PubMed ID: 1690476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of an alpha 1-adrenergic blocker (prazosin HCl) on micturition disturbances associated with benign prostatic hypertrophy.
    Shimizu K; Nakai K; Imai K; Yamanaka H
    Urol Int; 1990; 45 Suppl 1():36-9. PubMed ID: 1690479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of prazosin HCl in the treatment of urinary flow obstruction due to prostatic hypertrophy.
    Kondo A; Gotoh M; Saito M; Takita T; Kobayashi M; Otani T; Ito K
    Urol Int; 1990; 45 Suppl 1():4-17. PubMed ID: 1690480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of prazosin HCl on micturition disturbance associated with benign prostatic hypertrophy and bladder neck contracture.
    Kohama Y; Watanabe H; Sen Y; Yamamoto Y; Morioka M; Fujita Y
    Urol Int; 1990; 45 Suppl 1():26-9. PubMed ID: 1690477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prazosin HCl on the urethral pressure profile in patients with benign prostatic hyperplasia.
    Nakamura K; Kawashita E; Osumi Y; Usui T; Ishibe T
    Urol Int; 1990; 45 Suppl 1():30-5. PubMed ID: 1690478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, double-blind, placebo-controlled trial of the efficacy of prazosin in the treatment of dysuria associated with benign prostatic hypertrophy.
    Le Duc A; Cariou G; Baron C; Cukier J; Quentel P; Faure G; Rambeaud JJ; Navratil H; Costa P; Richaud JJ
    Urol Int; 1990; 45 Suppl 1():56-62. PubMed ID: 1690483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic effectiveness and safety of prazosin in the symptomatic treatment of benign prostatic hypertrophy].
    Jiménez Cruz JF; Server Pastor G; Rioja Sanz C; Salinas Casado J; Vela Navarrete R; Virseda Chamorro M
    Actas Urol Esp; 1990; 14(1):31-5. PubMed ID: 1692659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A twelve-week placebo-controlled study of prazosin in the treatment of prostatic obstruction.
    Chapple CR; Christmas TJ; Milroy EJ
    Urol Int; 1990; 45 Suppl 1():47-55. PubMed ID: 1690482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of effects of prazosin in patients with benign prostatic obstruction. A double-blind, multi-institutional, Paraprost-controlled study.
    Yamaguchi O; Shiraiwa Y; Kobayashi M; Yokota T; Ohinata M; Aoki H; Tsuzuki T; Ohori M
    Urol Int; 1990; 45 Suppl 1():40-6. PubMed ID: 1690481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 12-week placebo-controlled double-blind study of prazosin in the treatment of prostatic obstruction due to benign prostatic hyperplasia.
    Chapple CR; Stott M; Abrams PH; Christmas TJ; Milroy EJ
    Br J Urol; 1992 Sep; 70(3):285-94. PubMed ID: 1384919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical effects of distigmine bromide (Ubretid), a cholinesterase inhibitor, on micturition disturbance by benign prostatic hypertrophy--comparative study of distigmine bromide and the combination of distigmine bromide and adrenergic blocker].
    Katsumi T; Murayama K
    Hinyokika Kiyo; 1992 Sep; 38(9):1089-92. PubMed ID: 1384297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of desmopressin as an alternative in the treatment of nycturia in patients with benign prostatic hyperplasia (BPH)].
    Granados Loarca EA; Garat Barredo JM; Villavicencio Mavrich H
    Actas Urol Esp; 1999 Jan; 23(1):56-9. PubMed ID: 10089634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with the Peponen capsule in the management of benign prostatic hyperplasia.
    Hamvas A; Corradi G; Hegedüs M; Frang D
    Int Urol Nephrol; 1991; 23(1):51-5. PubMed ID: 1718920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A multicenter, fixed-flexible dose study of terazosin hydrochloride in the treatment of symptomatic benign prostatic hypertrophy].
    Park YC; Nishioka T; Arai Y; Tomoyoshi T; Kurita T; Hayashida H; Nagai N; Inoue H; Kataoka K; Kitagawa Y
    Hinyokika Kiyo; 1992 Jul; 38(7):857-68. PubMed ID: 1381869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical overview of prazosin in the treatment of prostatic obstruction.
    Milroy E
    Urol Int; 1990; 45 Suppl 1():1-3. PubMed ID: 1690474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the effectiveness of prazosin in conservative treatment of benign prostatic hypertrophy].
    Górecki R; Krzeski T; Wasik J; Borówka A
    Pol Tyg Lek; 1992 Jun 15-29; 47(24-26):549-51. PubMed ID: 1282713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Patterns of use of terazosine in current medical practice in ambulatory patients with obstructive and irritative obstructive disorders of urination].
    Serment G; Rossi D; Reitz C; Boumendil O
    Prog Urol; 2000 Apr; 10(2):254-60. PubMed ID: 10857143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of finasteride on invasive urodynamics and symptoms in the treatment of patients with bladder outflow obstruction due to benign prostatic hyperplasia.
    Tammela TL; Kontturi MJ
    J Urol; 1995 Oct; 154(4):1466-9. PubMed ID: 7544845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic effect of Robaveron tablet (KN-7) on urinary disturbance by benign prostatic hypertrophy].
    Sonoda T; Endo H; Maru A; Sasaki K; Kuroda K; Takamura T; Inada F; Rokuzyo M; Ohori T; Kubo T
    Hinyokika Kiyo; 1985 Mar; 31(3):553-62. PubMed ID: 2411118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prazosin in the treatment of prostatic obstruction. A placebo-controlled study.
    Kirby RS; Coppinger SW; Corcoran MO; Chapple CR; Flannigan M; Milroy EJ
    Br J Urol; 1987 Aug; 60(2):136-42. PubMed ID: 2444306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.